Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Accounts Payables (2019 - 2025)

IM Cannabis has reported Accounts Payables over the past 7 years, most recently at $8.6 million for Q4 2025.

  • Quarterly results put Accounts Payables at $8.6 million for Q4 2025, up 8.22% from a year ago — trailing twelve months through Dec 2025 was $8.6 million (up 8.22% YoY), and the annual figure for FY2025 was $8.6 million, up 5.86%.
  • Accounts Payables for Q4 2025 was $8.6 million at IM Cannabis, up from $8.0 million in the prior quarter.
  • Over the last five years, Accounts Payables for IMCC hit a ceiling of $11.3 million in Q4 2022 and a floor of $1.2 million in Q2 2024.
  • Median Accounts Payables over the past 5 years was $7.4 million (2024), compared with a mean of $6.6 million.
  • Biggest five-year swings in Accounts Payables: soared 204.67% in 2022 and later plummeted 39.94% in 2023.
  • IM Cannabis' Accounts Payables stood at $3.7 million in 2021, then soared by 204.67% to $11.3 million in 2022, then plummeted by 39.94% to $6.8 million in 2023, then rose by 17.91% to $8.0 million in 2024, then increased by 8.22% to $8.6 million in 2025.
  • The last three reported values for Accounts Payables were $8.6 million (Q4 2025), $8.0 million (Q4 2024), and $1.2 million (Q2 2024) per Business Quant data.